CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-08-13 | Aasen Thomas H EXEC VP, CFO AND CBO | Option exercise · Stock Option (right to buy) | −15,000 | 58,708 | ||
| 2013-06-07 | Wells William McDowall Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | BORER MICHAEL T Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | Brege Laura Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | GRAY MARY ANN Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | KAPLAN LESTER J PH D Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | Hacksell Uli CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2013-06-07 | Aasen Thomas H EXEC VP, CFO AND CBO | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2013-06-07 | Baity Glenn VP AND GC | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2013-06-07 | Mills Roger EVP, DEVELOPMENT AND CMO | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2013-06-07 | Rasmussen Torsten Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | Iversen Leslie L Director | Grant or award · Stock option (right to buy) | +14,000 | 14,000 | ||
| 2013-06-07 | BAKER BROS ADVISORS LLC Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | BAKER BROS ADVISORS LLC Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-07 | BAKER BROS ADVISORS LLC Director | Grant or award · Non-Qualified Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2013-06-05 | BAKER FELIX Director | Purchase | +26,577 | $14.46 | $384K | 1,446,934 |
| 2013-06-05 | BAKER FELIX Director | Purchase | +217,986 | $14.46 | $3.2M | 17,458,344 |
| 2013-06-05 | BAKER FELIX Director | Purchase | +5,437 | $14.46 | $79K | 427,263 |
| 2013-06-05 | BAKER FELIX Director | Purchase | +21,080 | $14.58 | $307K | 1,468,014 |
| 2013-06-05 | BAKER FELIX Director | Purchase | +172,893 | $14.58 | $2.5M | 17,631,237 |
Page 72 of 81 · 1,609 trades